ZYTO Acquisition Announced.

OREM, Utah -- ZYTO Corp. (OTCBB: ZYTC)

July 31, 2006, Quiver Corp., a Delaware corporation ("Quiver"), Pinnacle Transportation Lines Inc., a Delaware corporation ("Pinnacle") and Pinnacle Transportation Lines Merger Sub Inc., also a Delaware corporation ("Merger Sub") entered into an Agreement and Plan of Merger ("Reorganization"), effecting a reverse triangular merger and holding company formation in which Quiver became a holding company and Pinnacle merged into Merger Sub. Under the terms of the Reorganization, shareholders of Pinnacle were entitled to receive an equivalent number of shares of Quiver. Prior to the Reorganization, Quiver was a wholly owned subsidiary of Pinnacle, and Merger Sub was a wholly owned subsidiary of Quiver. The Reorganization created a holding company structure under which Quiver was the parent company with the same shareholder base that Pinnacle had prior to the Reorganization.

On Sept. 6, 2006, Quiver entered into a Share Exchange Agreement (the "Exchange") with ZYTO Corp., a Nevada corporation ("ZYTO"), and the shareholders of ZYTO. Under the terms of the Exchange, Quiver acquired all of the equity of ZYTO. Upon completion of the Exchange, ZYTO became a wholly owned subsidiary of Quiver, and Quiver changed its name to ZYTO Corp. The new trading symbol is ZYTC.

As the global leader in bio-interactive technology, ZYTO stands at the cutting edge of two decades of technological evolution. During those years, the ZYTO staff has specialized in designing and operating bio-interactive technology. ZYTO is expert at building hardware and software applications that interactively link biology and technology to obtain information and an outcome surpassing what was recently believed possible.

ZYTO's core application is embodied in a stimulus-response system called the LSA System. The LSA capitalizes on the body's ability to respond to subtle, specific computer-generated stressors, called virtual stressors. Using patent-pending methods and technology, the LSA correlates the interchange between the stimulus from the computer and the response from the person or animal being assessed. Clinicians using the LSA System have the advantage of delivering better, patient-specific therapy and prescriptions.

For more information: www.ZYTO.com.

This press release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Words such as "expect," "anticipate," "may," "will," "plan," "intend," "estimate," "could," and other similar expressions are intended to identify these forward-looking statements. ZYTO does not assure the future results or outcome of the matters described in forward-looking statements; rather, these statements merely reflect current expectations of the approximate outcomes of the matters discussed. These statements by ZYTO are subject to certain risks, including, among others, the ability of the parties to perform their obligations, general economic conditions, reactions from customers and suppliers from the announcement of the merger, and other risks detailed from time to time in the company's periodic reports.